Westover Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,989
| Closed | -$238K | – | 243 |
|
|
2024
Q4 | $238K | Sell |
8,989
-3,375
| -27% | -$89.5K | 0.05% | 208 |
|
|
2024
Q3 | $358K | Buy |
12,364
+5,160
| +72% | +$149K | 0.07% | 184 |
|
|
2024
Q2 | $202K | Sell |
7,204
-102
| -1% | -$2.85K | 0.05% | 209 |
|
|
2024
Q1 | $203K | Sell |
7,306
-2,675
| -27% | -$74.2K | 0.06% | 179 |
|
|
2023
Q4 | $287K | Sell |
9,981
-1,560
| -14% | -$44.9K | 0.09% | 144 |
|
|
2023
Q3 | $383K | Hold |
11,541
| – | – | 0.14% | 114 |
|
|
2023
Q2 | $423K | Sell |
11,541
-1,269
| -10% | -$46.5K | 0.15% | 110 |
|
|
2023
Q1 | $523K | Hold |
12,810
| – | – | 0.19% | 92 |
|
|
2022
Q4 | $656K | Buy |
12,810
+355
| +3% | +$18.2K | 0.26% | 82 |
|
|
2022
Q3 | $545K | Buy |
12,455
+3,870
| +45% | +$169K | 0.21% | 88 |
|
|
2022
Q2 | $450K | Hold |
8,585
| – | – | 0.17% | 99 |
|
|
2022
Q1 | $444K | Hold |
8,585
| – | – | 0.14% | 106 |
|
|
2021
Q4 | $507K | Sell |
8,585
-1,530
| -15% | -$90.4K | 0.15% | 111 |
|
|
2021
Q3 | $435K | Buy |
10,115
+1,744
| +21% | +$75K | 0.14% | 109 |
|
|
2021
Q2 | $328K | Sell |
8,371
-210
| -2% | -$8.23K | 0.11% | 134 |
|
|
2021
Q1 | $311K | Sell |
8,581
-1,316
| -13% | -$47.7K | 0.11% | 131 |
|
|
2020
Q4 | $364K | Sell |
9,897
-2,373
| -19% | -$87.3K | 0.13% | 110 |
|
|
2020
Q3 | $427K | Buy |
+12,270
| New | +$427K | 0.18% | 93 |
|
|
2019
Q3 | – | Sell |
-5,752
| Closed | -$236K | – | 143 |
|
|
2019
Q2 | $236K | Buy |
5,752
+22
| +0.4% | +$903 | 0.12% | 123 |
|
|
2019
Q1 | $231K | Buy |
+5,730
| New | +$231K | 0.12% | 120 |
|
|
2017
Q2 | – | Sell |
-26,302
| Closed | -$854K | – | 116 |
|
|
2017
Q1 | $854K | Buy |
26,302
+3,582
| +16% | +$116K | 0.57% | 55 |
|
|
2016
Q4 | $700K | Sell |
22,720
-9,588
| -30% | -$295K | 0.5% | 55 |
|
|
2016
Q3 | $1.04M | Buy |
+32,308
| New | +$1.04M | 0.77% | 46 |
|